HLPR:CA:TSX-Mainstreet Health Investments Inc Subscription Rcpt (CAD)

EQUITY | Preferred Share Fixed Income | Toronto Stock Exchange

Last Closing

CAD 25.42

Change

+0.08 (+0.32)%

Market Cap

CAD 0.10B

Volume

500.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-29 )

ETFs Containing HLPR:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Preferred Share Fixed Income) Market Performance vs. Exchange (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.33% 100% F 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.33% 83% B 79% B-
Trailing 12 Months  
Capital Gain 17.14% 100% F 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.14% 83% B 73% C
Trailing 5 Years  
Capital Gain 27.04% 100% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.04% 92% A 53% F
Average Annual (5 Year Horizon)  
Capital Gain 5.74% 100% F 62% D
Dividend Return 5.74% 85% B 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.22% 46% F 44% F
Risk Adjusted Return 28.40% 85% B 56% F
Market Capitalization 0.10B 46% F 37% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Preferred Share Fixed Income) Ratio vs. Market (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.